A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Hadassah Medical Organization
British Columbia Cancer Agency
Instituto do Cancer do Estado de São Paulo
Memorial Sloan Kettering Cancer Center
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
GlaxoSmithKline
Shenzhen Second People's Hospital
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center